Interleukin-2 induction of T-cell G1 progression and c-myb expression

Science. 1986 Jul 11;233(4760):203-6. doi: 10.1126/science.3523754.

Abstract

In studies to determine the biochemical mechanisms responsible for cell proliferation, synchronized T cells were used as a model for cellular growth control. By metabolic and morphologic criteria, it was found that activation of the T-cell antigen receptor rendered the cells responsive to interleukin-2 (IL-2), but did not move them through the cell cycle. Instead, IL-2 stimulated G1 progression to S phase, or lymphocyte "blastic transformation." During IL-2-promoted G1 progression, expression of the cellular proto-oncogene c-myb was induced transiently at six to seven times basal levels, maximal levels occurring at the midpoint of G1.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Cycle / drug effects
  • Cell Division / drug effects*
  • Gene Expression Regulation / drug effects
  • Humans
  • Interleukin-2 / pharmacology*
  • Mice
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins / biosynthesis
  • Proto-Oncogenes* / drug effects
  • Receptors, Antigen, T-Cell / drug effects
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / growth & development*

Substances

  • Interleukin-2
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins
  • Receptors, Antigen, T-Cell